| human | Q5 |
| P2287 | CRIStin ID | 58112 |
| P496 | ORCID iD | 0000-0001-8887-6100 |
| P2038 | ResearchGate profile ID | Ellisiv-Mathiesen-2 |
| P27 | country of citizenship | Norway | Q20 |
| P108 | employer | University of Tromsø – The Arctic University of Norway | Q279724 |
| P734 | family name | Mathiesen | Q21510991 |
| Mathiesen | Q21510991 | ||
| Mathiesen | Q21510991 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q56836084 | 40 EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004 |
| Q33481614 | A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke |
| Q82737853 | Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study |
| Q37920970 | Age and gender differences in incidence and case fatality trends for myocardial infarction: a 30-year follow-up. The Tromso Study. |
| Q46031881 | Albuminuria and carotid atherosclerosis as predictors of cognitive function in a general population. |
| Q79389702 | Albuminuria as risk factor for initiation and progression of carotid atherosclerosis in non-diabetic persons: the Tromsø Study |
| Q46193186 | Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events |
| Q30252371 | Alcohol Consumption and Common Carotid Intima-Media Thickness: The USE-IMT Study |
| Q104505107 | An incomplete Circle of Willis is not a risk factor for white matter hyperintensities: The Tromsø Study |
| Q84734816 | Anthropometric measures of obesity and risk of venous thromboembolism: the Tromso study |
| Q91764288 | Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium |
| Q35899571 | Association between diastolic dysfunction and future atrial fibrillation in the Tromsø Study from 1994 to 2010. |
| Q84967986 | Association between headache and serum 25-hydroxyvitamin D: the Tromsø Study: Tromsø 6 |
| Q47668071 | Association of occasional smoking with total mortality in the population-based Tromsø study, 2001-2015. |
| Q37170991 | Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins: The Tromsø Study |
| Q36135460 | Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study |
| Q47833921 | Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke. |
| Q39110358 | Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study |
| Q47770562 | Atrial fibrillation is associated with cognitive decline in stroke-free subjects: the Tromsø Study. |
| Q99631227 | Atrial fibrillation, venous thromboembolism, ischemic stroke, and all-cause mortality: The Tromsø study |
| Q49622773 | Blood pressure target achievement and antihypertensive medication use in women and men after first-ever myocardial infarction: the Tromsø Study 1994-2016. |
| Q47434717 | Body height and risk of venous thromboembolism: The Tromsø Study |
| Q84453968 | Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study |
| Q40765309 | Burden of Cancer in a Large Consortium of Prospective Cohorts in Europe |
| Q38669847 | C-reactive protein in atherosclerosis - A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study |
| Q48720506 | C-reactive protein, obesity, and the risk of arterial and venous thrombosis |
| Q37236716 | CHA2DS2-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study |
| Q35164599 | Cardiovascular health and the modifiable burden of incident myocardial infarction: the Tromsø Study |
| Q57730771 | Cardiovascular risk estimation tailored to different clinical settings – the Tromsø study |
| Q90385496 | Carotid Intima-Media Thickness Versus Carotid Plaque Burden for Predicting Cardiovascular Risk |
| Q63380980 | Carotid Plaque Area and Intima-Media Thickness in Prediction of First-Ever Ischemic Stroke |
| Q60690178 | Carotid Plaque Echogenicity and Risk of Nonvertebral Fractures in Women: A Longitudinal Population-Based Study |
| Q48691354 | Carotid artery plaque progression and cognitive decline: the Tromsø Study 1994-2008. |
| Q44902257 | Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsø Study |
| Q39323127 | Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study |
| Q48765537 | Carotid atherosclerosis predicts lower cognitive test results: a 7-year follow-up study of 4,371 stroke-free subjects - the Tromsø study |
| Q36087284 | Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration |
| Q34249847 | Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data |
| Q37353240 | Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease |
| Q51664920 | Clinically significant novel biomarkers for prediction of first ever myocardial infarction: the Tromsø Study. |
| Q30252911 | Clustering of cardiovascular risk factors and carotid intima-media thickness: The USE-IMT study |
| Q37317224 | Cognitive function, drusen, and age-related macular degeneration: a cross-sectional study |
| Q36195869 | Cohort profile: the Tromso Study |
| Q30371511 | Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative. |
| Q30371516 | Common carotid intima-media thickness measurements do not improve cardiovascular risk prediction in individuals with elevated blood pressure: the USE-IMT collaboration. |
| Q43668742 | Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis |
| Q41522124 | Common carotid intima-media thickness relates to cardiovascular events in adults aged <45 years |
| Q44415750 | Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study |
| Q42393726 | Correction: Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study |
| Q57399028 | Correction: Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - Results from the PROG-IMT collaboration |
| Q55564481 | Correction: The metabolic syndrome and progression of carotid atherosclerosis over 13 years: the Tromsø study. |
| Q91163714 | Corrigendum to "Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Tromsø study" [Atherosclerosis 271 (April 2018) 1-8] |
| Q63380964 | Cystatin C as risk factor for cardiovascular events and all-cause mortality in the general population. The Tromsø Study |
| Q38966561 | Declining Incidence of Ischemic Stroke: What Is the Impact of Changing Risk Factors? The Tromsø Study 1995 to 2012. |
| Q80820451 | Delayed metabolism of postprandial triglyceride-rich lipoproteins in subjects with echolucent carotid plaques |
| Q73836713 | Diabetes and accident insurance. A 3-year follow-up of 7,599 insured diabetic individuals |
| Q92307092 | Does insomnia modify the association between C-reactive protein and migraine? The Tromsø Study 2015-2016 |
| Q43745076 | Echocardiographic screening of the general population and long-term survival: a randomized clinical study |
| Q48874089 | Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromsø study |
| Q61807794 | Effect of Genetically Low 25-Hydroxyvitamin D on Mortality Risk: Mendelian Randomization Analysis in 3 Large European Cohorts |
| Q94547296 | Effect of adiposity on differences in carotid plaque burden in studies conducted in Norway and Russia: a cross-sectional analysis of two populations at very different risk of cardiovascular mortality |
| Q91659344 | Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study |
| Q47739610 | Electrocardiographic unrecognized myocardial infarction does not improve prediction of cardiovascular events beyond traditional risk factors. The Tromsø Study |
| Q46606954 | Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromsø study |
| Q79811138 | Endothelial dysfunction and systemic inflammation in persons with echolucent carotid plaques |
| Q52990537 | Estimated and Measured GFR Associate Differently with Retinal Vasculopathy in the General Population. |
| Q37370182 | Evaluation of serum 25-hydroxyvitamin d as a predictor of carotid intima-media thickness and carotid total plaque area in nonsmokers: the tromsø study |
| Q48623207 | Family history of myocardial infarction and cause-specific risk of myocardial infarction and venous thromboembolism: the Tromsø Study |
| Q40065141 | Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study |
| Q54963379 | Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study. |
| Q57074655 | Gender differences in the association of syndecan-4 with myocardial infarction: The population-based Tromsø Study |
| Q35877398 | Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study |
| Q45263603 | HDL-cholesterol and future risk of venous thromboembolism: the Tromsø Study |
| Q31044366 | HbA1c levels in non-diabetic older adults - No J-shaped associations with primary cardiovascular events, cardiovascular and all-cause mortality after adjustment for confounders in a meta-analysis of individual participant data from six cohort studie |
| Q33632252 | Hematocrit and risk of venous thromboembolism in a general population. The Tromso study |
| Q87705627 | High fish plus fish oil intake is associated with slightly reduced risk of venous thromboembolism: the Tromsø Study |
| Q35143506 | High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study |
| Q40751055 | Hospital volume and 1-year mortality after treatment of intracranial aneurysms: a study based on patient registries in Scandinavia |
| Q95654590 | Hypothetical interventions and risk of myocardial infarction in a general population: application of the parametric g-formula in a longitudinal cohort study-the Tromsø Study |
| Q48320737 | Hypothetical interventions to prevent stroke: an application of the parametric g-formula to a healthy middle-aged population |
| Q93092140 | Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study |
| Q93091993 | Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study |
| Q43961510 | Impact of cardiovascular risk factors on cognitive function: the Tromsø study |
| Q40809604 | Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study |
| Q39308918 | Impact of incident venous thromboembolism on risk of arterial thrombotic diseases |
| Q92262557 | Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism |
| Q43555804 | Incidence and mortality of aneurysmal subarachnoid hemorrhage in two Norwegian cohorts, 1984-2007. |
| Q51142244 | Incidence of aneurysmal subarachnoid hemorrhage in Norway, 1999-2007. |
| Q80838424 | Increased thrombin generation in persons with echogenic carotid plaques |
| Q42026879 | Individual progression of carotid intima media thickness as a surrogate for vascular risk (PROG-IMT): Rationale and design of a meta-analysis project |
| Q39539994 | Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study |
| Q30870962 | Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration |
| Q49916343 | Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Tromsø Study |
| Q37556055 | Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study |
| Q55422210 | Joint Effect of Carotid Plaque and C-Reactive Protein on First-Ever Ischemic Stroke and Myocardial Infarction? |
| Q83936731 | Joint effect of modifiable risk factors on the risk of aneurysmal subarachnoid hemorrhage: a cohort study |
| Q47379001 | Joint effects of obesity and body height on the risk of venous thromboembolism: the Tromsø Study |
| Q126036067 | Know Your Heart: Rationale, design and conduct of a cross-sectional study of cardiovascular structure, function and risk factors in 4500 men and women aged 35-69 years from two Russian cities, 2015-18 |
| Q57657283 | Know Your Heart: Rationale, design and conduct of a cross-sectional study of cardiovascular structure, function and risk factors in 4500 men and women aged 35-69 years from two Russian cities, 2015-18 |
| Q46912375 | Lack of significant association between intima-media thickness in the carotid artery and serum TSH level. The Tromsø Study |
| Q91729528 | Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromsø Study |
| Q63380956 | Long-term cardiovascular consequences of Rose angina at age 20–54 years: 29-years’ follow-up of the Tromsø Study |
| Q46369282 | Long-term use of lipid-lowering drugs slows progression of carotid atherosclerosis: the Tromso study 1994 to 2008. |
| Q40714406 | Longitudinal and Secular Trends in Blood Pressure Among Women and Men in Birth Cohorts Born Between 1905 and 1977: The Tromsø Study 1979 to 2008. |
| Q38615571 | Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905-1977 in the population-based Tromsø Study 1979-2016. |
| Q83355654 | Low testosterone levels are associated with carotid atherosclerosis in men |
| Q33626208 | Macular thickness in healthy eyes of adults (N = 4508) and relation to sex, age and refraction: the Tromsø Eye Study (2007-2008). |
| Q37562875 | Magnetic Resonance Volumetry: Prediction of Subjective Memory Complaints and Mild Cognitive Impairment, and Associations with Genetic and Cardiovascular Risk Factors |
| Q39973632 | Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, Tromsø, Norway |
| Q50881899 | Mild cognitive impairment, risk factors and magnetic resonance volumetry: role of probable Alzheimer's disease in the family. |
| Q43002269 | Moderate wine consumption is associated with better cognitive test results: a 7 year follow up of 5033 subjects in the Tromsø Study |
| Q40440990 | Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Tromsø Study |
| Q38760099 | Myocardial infarction and future risk of cancer in the general population-the Tromsø Study. |
| Q89943255 | Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study |
| Q28385306 | N-Acetyl-β-D-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population |
| Q92245367 | Neuropsychological functions of verbal recall and psychomotor speed significantly affect pain tolerance |
| Q37860702 | No detectable Chlamydia pneumoniae and cytomegalovirus DNA in leukocytes in subjects with echolucent and echogenic carotid artery plaques |
| Q33991765 | No large-effect low-frequency coding variation found for myocardial infarction |
| Q39178689 | Normative values for carotid intima media thickness and its progression: Are they transferrable outside of their cohort of origin? |
| Q85296595 | Obesity measures and risk of venous thromboembolism and myocardial infarction |
| Q43773514 | Osteoprotegerin is associated with hip fracture incidence: the Tromso Study |
| Q39617292 | Palpitations are predictive of future atrial fibrillation. An 11-year follow-up of 22,815 men and women: the Tromsø Study |
| Q34371104 | Physical activity and risk of venous thromboembolism. The Tromso study |
| Q34287442 | Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study |
| Q55133310 | Population distribution of traditional and the emerging cardiovascular risk factors carotid plaque and IMT: the REFINE-Reykjavik study with comparison with the Tromsø study. |
| Q36608083 | Prediction of asymptomatic carotid artery stenosis in the general population: identification of high-risk groups |
| Q52591836 | Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - Results from the PROG-IMT collaboration. |
| Q30604701 | Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis |
| Q90750628 | Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium |
| Q30279079 | Race/Ethnic Differences in the Associations of the Framingham Risk Factors with Carotid IMT and Cardiovascular Events |
| Q82252963 | Recurrence and long-term maternal health risks of hypertensive disorders of pregnancy: a population-based study |
| Q100417722 | Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study |
| Q50452821 | Red cell distribution width and carotid atherosclerosis progression. The Tromsø Study. |
| Q50438184 | Red cell distribution width is associated with future risk of incident stroke. The Tromsø Study |
| Q35026417 | Red cell distribution width is associated with incident myocardial infarction in a general population: the Tromsø Study |
| Q52002101 | Reduced neuropsychological test performance in asymptomatic carotid stenosis: The Tromsø Study. |
| Q37782447 | Relation between serum osteoprotegerin and carotid intima media thickness in a general population – the Tromsø Study |
| Q47913950 | Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study |
| Q81644848 | Repeated visual and computer-assisted carotid plaque characterization in a longitudinal population-based ultrasound study: the Tromsø study |
| Q48454484 | Response to letter regarding article, "Impact of incident venous thromboembolism on risk of arterial thrombotic diseases". |
| Q40867546 | Resting heart rate predicts incident myocardial infarction, atrial fibrillation, ischaemic stroke and death in the general population: the Tromsø Study |
| Q63380935 | Resting heart rate trajectories and myocardial infarction, atrial fibrillation, ischaemic stroke and death in the general population: The Tromsø Study |
| Q35086237 | Retinal vascular calibre and response to light exposure and serial imaging |
| Q44674712 | Retinal vascular calibres are significantly associated with cardiovascular risk factors: the Tromsø Eye Study |
| Q84599527 | Risk factors for aneurysmal subarachnoid hemorrhage - BMI and serum lipids: 11-year follow-up of the HUNT and the Tromsø Study in Norway |
| Q47822482 | Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromsø Study. |
| Q73264966 | Risk of stroke in carotid stenosis--what is the role of plaque morphology? |
| Q37770395 | Seasonal variation in incidence of acute myocardial infarction in a sub-Arctic population: the Tromsø Study 1974-2004. |
| Q52681815 | Secondary prevention care and effect: Total and low-density lipoprotein cholesterol levels and lipid-lowering drug use in women and men after incident myocardial infarction - The Tromsø Study 1994-2016. |
| Q47995454 | Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study |
| Q48949895 | Serum ferritin and hemoglobin are independently associated with wider retinal venular caliber: the Tromsø Study 2001-2008. |
| Q39090351 | Serum osteoprotegerin and future risk of cancer and cancer-related mortality in the general population: the Tromsø study |
| Q33793497 | Serum osteoprotegerin and renal function in the general population: the Tromsø Study |
| Q39787548 | Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study |
| Q83168044 | Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans |
| Q34940502 | Serum osteoprotegerin levels are related to height loss: the Tromsø Study |
| Q43175422 | Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population--the Tromsø study |
| Q57309310 | Several common variants modulate heart rate, PR interval and QRS duration |
| Q47644063 | Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe). |
| Q55499184 | Sex Differences in the Impact of Body Mass Index on the Risk of Future Atrial Fibrillation: Insights From the Longitudinal Population-Based Tromsø Study. |
| Q44879818 | Sex differences in risk factors for aneurysmal subarachnoid hemorrhage: a cohort study |
| Q34391105 | Single-nucleotide polymorphism, rs1799941 in the Sex Hormone-Binding Globulin (SHBG) gene, related to both serum testosterone and SHBG levels and the risk of myocardial infarction, type 2 diabetes, cancer and mortality in men: the Tromsø Study |
| Q47880681 | Small and large vessel disease in persons with unrecognized compared to recognized myocardial infarction: The Tromsø Study 2007-2008. |
| Q114061837 | Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST) |
| Q46097302 | Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial |
| Q44740999 | Subclinical cardiovascular disease is associated with a high glomerular filtration rate in the nondiabetic general population |
| Q37895309 | Subclinical carotid atherosclerosis and cognitive function |
| Q34213805 | Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk |
| Q37293606 | Temporal Trends in Incidence and Case Fatality of Intracerebral Hemorrhage: The Tromsø Study 1995-2012. |
| Q91330550 | Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality |
| Q46569874 | The ApoC-I content of VLDL particles is associated with plaque size in persons with carotid atherosclerosis |
| Q35620695 | The DBP Phenotype Gc-1f/Gc-1f Is Associated with Reduced Risk of Cancer. The Tromsø Study |
| Q31129827 | The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases |
| Q50123693 | The Tromsø Eye Study: study design, methodology and results on visual acuity and refractive errors |
| Q40572648 | The Tromsø study 1974-2016: 40 years of cardiovascular research |
| Q42825544 | The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid atherosclerosis |
| Q90402581 | The association between anthropometric measures of adiposity and the progression of carotid atherosclerosis |
| Q39996086 | The association between inflammatory markers and carotid atherosclerosis is sex dependent: the Tromsø Study |
| Q90480607 | The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer |
| Q61829406 | The contribution of obesity to carotid atherosclerotic plaque burden in a general population sample in Norway: The Tromsø Study |
| Q90594974 | The impact of risk factor trends on intracerebral hemorrhage incidence over the last two decades-The Tromsø Study |
| Q91462137 | The independent and joint associations of physical activity and body mass index with myocardial infarction: The Tromsø Study |
| Q36517372 | The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study |
| Q47216855 | The phosphodiesterase 8B gene rs4704397 is associated with thyroid function, risk of myocardial infarction, and body height: the Tromsø study |
| Q37944189 | The role of hypertension in the development of nephropathy in type 1 (insulin-dependent) diabetes mellitus |
| Q34557834 | The sixth survey of the Tromso Study (Tromso 6) in 2007-08: collaborative research in the interface between clinical medicine and epidemiology: study objectives, design, data collection procedures, and attendance in a multipurpose population-based h |
| Q40270494 | Time trends in incidence and case fatality of ischemic stroke: the tromsø study 1977-2010. |
| Q40305475 | Trends in Modifiable Risk Factors Are Associated With Declining Incidence of Hospitalized and Nonhospitalized Acute Coronary Heart Disease in a Population |
| Q46502440 | Trends in cardiovascular risk factors across levels of education in a general population: is the educational gap increasing? The Tromsø study 1994-2008. |
| Q37536085 | Ultrasonographic measurements of subclinical carotid atherosclerosis in prediction of ischemic stroke |
| Q39357608 | Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women--the Tromso Study |
| Q33577406 | Uric acid predicts mortality and ischaemic stroke in subjects with diastolic dysfunction: the Tromsø Study 1994-2013 |
| Q101213265 | Variations in the Circle of Willis in a large population sample using 3D TOF angiography: The Tromsø Study |
| Q37648426 | Venous thromboembolism increases the risk of atrial fibrillation: the Tromso study |
| Q41656059 | Vitamin D and cognitive function: The Tromsø Study |
| Q31162503 | Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium |
| Q22306553 | Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States |
| Q43180196 | Weight loss and mortality: a gender-specific analysis of the Tromsø study |
| Q109309676 | Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants |
| Q83864790 | [Carotid surgery--why, when and for whom?] |
| Q79961966 | [Risk factors for cerebral stroke] |
Search more.